Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Aspen Aerogels, Inc.NYSE: ASPN
Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue rises 730.7% from a year ago
Deferred revenue stood at $21.97M at the end of Q1 FY2026, up 730.7% from a year earlier and up 1645.1% from the prior quarter. Over 3 fiscal years it compounded at -40.1% a year.
Context
- Deferred revenue amounted to 5.4% of total assets at the end of Q1 FY2026, up 4.9 pp from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +730.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 1.26M USD
- Year-over-year change
- -42.7%
- 4-year CAGR
- -32.5%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.26M | -42.7% |
| FY2024 | 2024-12-31 | 2.2M | -5.1% |
| FY2023 | 2023-12-31 | 2.32M | -60.4% |
| FY2022 | 2022-12-31 | 5.85M | -3.4% |
| FY2021 | 2021-12-31 | 6.05M | — |
Deferred Revenue vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so deferred revenue is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +730.7% is the highest of 7, against a peer median of +2.7%.
- Deferred revenue amounts to 5.4% of total assets for ASPN, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Feb 2026 | $60.9M USD | +73.1% | +29.5% | 5.4% | |
| Mar 2026 | CN¥60.09M CNY | +5.4% | +43.5% | 3.1% | |
| Mar 2026 | $49.6M USD | -5.0% | -30.5% | 2.5% | |
| Mar 2026 | $21.97M USD | +730.7% | -40.1% | 5.4% | |
| Dec 2025 | €11.95M EUR | +75.5% | -20.3% | 13.2% | |
| Mar 2026 | $11.3M USD | — | — | 0.2% | |
| Apr 2026 | $3.94M USD | +0.0% | +0.0% | 0.2% | |
| Mar 2026 | $1.53M USD | -14.8% | -35.5% | 0.2% | |
| Apr 2026 | $0 USD | — | +43.8% | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ASPN) | — | +2.7% | +0.0% | 0.2% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 76.56M | 281.34M | 139.72M | 220.88M | 156.86M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 20.43M | 57.35M | 70M | 109.1M | 35.27M |
| Inventory | 11.99M | 22.54M | 39.19M | 47.55M | 38.25M |
| Other Current Assets | 390K | 8.46M | 17.42M | 31.91M | 11.68M |
| Total Current Assets | 112.15M | 369.69M | 266.33M | 409.45M | 242.05M |
| Property, Plant & Equipment (Net) | 69.31M | 271.21M | 434.44M | 480.13M | 122.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.5M | 2.52M | 2.28M | 5.57M | 42.08M |
| Total Non-current Assets | 70.8M | 273.73M | 436.72M | 485.7M | 164.63M |
| Total Assets | 182.95M | 643.42M | 703.05M | 895.14M | 406.68M |
| Account Payables | 17.44M | 54.73M | 51.09M | 44.36M | 13.24M |
| Short-term Debt | 0 | 0 | 0 | 23.78M | 25.12M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 6.05M | 5.85M | 2.32M | 2.2M | 1.26M |
| Other Current Liabilities | 8.99M | 12.47M | 16.88M | 19.37M | 2.93M |
| Total Current Liabilities | 36.56M | 78.95M | 78.1M | 110.11M | 62.03M |
| Long-term Debt | 0 | 103.58M | 114.99M | 137.09M | 79.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 5M | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 17.99M | 117.04M | 136.9M | 170.33M | 109.14M |
| Total Liabilities | 54.55M | 195.98M | 214.99M | 280.44M | 171.16M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (545.05M) | (627.79M) | (673.6M) | (660.23M) | (1.05B) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | (0) | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 128.41M | 447.44M | 488.06M | 614.71M | 235.52M |
| Total Debt | 15.24M | 119.4M | 138.77M | 197.38M | 143.71M |
| Net Debt | (61.33M) | (161.93M) | (951K) | (23.5M) | (13.15M) |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.